To KKW - Search Results

1

Drug repurposing to overcome resistance to various therapies for colorectal cancer.

Fong W, To KKW. Fong W, et al. Among authors: to kkw. Cell Mol Life Sci. 2019 Sep;76(17):3383-3406. doi: 10.1007/s00018-019-03134-0. Epub 2019 May 13. Cell Mol Life Sci. 2019. PMID: 31087119 Free PMC article. Review.

2

Exploiting a novel miR-519c-HuR-ABCG2 regulatory pathway to overcome chemoresistance in colorectal cancer.

To KK, Leung WW, Ng SS. To KK, et al. Exp Cell Res. 2015 Nov 1;338(2):222-31. doi: 10.1016/j.yexcr.2015.09.011. Epub 2015 Sep 18. Exp Cell Res. 2015. PMID: 26386386

3

A platinum-based hybrid drug design approach to circumvent acquired resistance to molecular targeted tyrosine kinase inhibitors.

Wei Y, Poon DC, Fei R, Lam AS, Au-Yeung SC, To KK. Wei Y, et al. Sci Rep. 2016 May 6;6:25363. doi: 10.1038/srep25363. Sci Rep. 2016. PMID: 27150583 Free PMC article.

4

Drug combination approach to overcome resistance to EGFR tyrosine kinase inhibitors in lung cancer.

Tong CWS, Wu WKK, Loong HHF, Cho WCS, To KKW. Tong CWS, et al. Among authors: to kkw. Cancer Lett. 2017 Oct 1;405:100-110. doi: 10.1016/j.canlet.2017.07.023. Epub 2017 Jul 31. Cancer Lett. 2017. PMID: 28774798 Review.

5

CUDC-907, a dual HDAC and PI3K inhibitor, reverses platinum drug resistance.

To KKW, Fu LW. To KKW, et al. Invest New Drugs. 2018 Feb;36(1):10-19. doi: 10.1007/s10637-017-0501-9. Epub 2017 Aug 17. Invest New Drugs. 2018. PMID: 28819699

6

MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.

To KK, Tong CW, Wu M, Cho WC. To KK, et al. World J Gastroenterol. 2018 Jul 21;24(27):2949-2973. doi: 10.3748/wjg.v24.i27.2949. World J Gastroenterol. 2018. PMID: 30038463 Free PMC article. Review.

7

Advances in the discovery of microRNA-based anticancer therapeutics: latest tools and developments.

To KKW, Fong W, Tong CWS, Wu M, Yan W, Cho WCS. To KKW, et al. Expert Opin Drug Discov. 2020 Jan;15(1):63-83. doi: 10.1080/17460441.2020.1690449. Epub 2019 Nov 19. Expert Opin Drug Discov. 2020. PMID: 31739699 Review.

8

Updates on the use of liposomes for active tumor targeting in cancer therapy.

Yan W, Leung SS, To KK. Yan W, et al. Nanomedicine (Lond). 2020 Feb;15(3):303-318. doi: 10.2217/nnm-2019-0308. Epub 2019 Dec 5. Nanomedicine (Lond). 2020. PMID: 31802702 Review.

9

Flavonoids potentiated anticancer activity of cisplatin in non-small cell lung cancer cells in vitro by inhibiting histone deacetylases.

Yan W, Wu THY, Leung SSY, To KKW. Yan W, et al. Among authors: to kkw. Life Sci. 2020 Oct 1;258:118211. doi: 10.1016/j.lfs.2020.118211. Epub 2020 Aug 6. Life Sci. 2020. PMID: 32768576

10

Repurposing of niclosamide as a STAT3 inhibitor to enhance the anticancer effect of chemotherapeutic drugs in treating colorectal cancer.

Wu MM, Zhang Z, Tong CWS, Yan VW, Cho WCS, To KKW. Wu MM, et al. Among authors: to kkw. Life Sci. 2020 Dec 1;262:118522. doi: 10.1016/j.lfs.2020.118522. Epub 2020 Oct 2. Life Sci. 2020. PMID: 33011217

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

499 results

Search Page

Filters